CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $7,414 | +117.4% | 2,200 | 0.0% | 0.00% | – |
| Q4 2022 | $3,410 | -93.9% | 2,200 | -70.2% | 0.00% | -100.0% |
| Q2 2021 | $56,000 | -5.1% | 7,380 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $59,000 | -3.3% | 7,380 | -3.9% | 0.00% | -33.3% |
| Q3 2020 | $61,000 | +38.6% | 7,680 | +35.2% | 0.00% | 0.0% |
| Q1 2020 | $44,000 | +266.7% | 5,680 | +83.8% | 0.00% | +200.0% |
| Q4 2019 | $12,000 | -47.8% | 3,090 | -11.7% | 0.00% | 0.0% |
| Q3 2019 | $23,000 | 0.0% | 3,500 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $23,000 | +109.1% | 3,500 | +133.3% | 0.00% | 0.0% |
| Q1 2019 | $11,000 | -56.0% | 1,500 | -76.8% | 0.00% | -85.7% |
| Q1 2016 | $25,000 | -30.6% | 6,460 | 0.0% | 0.01% | -41.7% |
| Q4 2015 | $36,000 | -12.2% | 6,460 | 0.0% | 0.01% | 0.0% |
| Q3 2015 | $41,000 | -2.4% | 6,460 | 0.0% | 0.01% | 0.0% |
| Q2 2015 | $42,000 | -14.3% | 6,460 | -3.0% | 0.01% | -14.3% |
| Q1 2015 | $49,000 | – | 6,660 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CM Management, LLC | 450,000 | $846,000 | 0.90% |
| Skylands Capital, LLC | 2,944,670 | $5,535,980 | 0.84% |
| Sargent Investment Group, LLC | 1,257,048 | $2,363,250 | 0.57% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 197,940 | $372,127 | 0.52% |
| Avenir Corp | 2,717,397 | $5,108,706 | 0.48% |
| Granahan Investment Management | 1,552,393 | $2,918,499 | 0.10% |
| Seelaus Asset Management LLC | 20,450 | $38,446 | 0.04% |
| HighMark Wealth Management LLC | 10,000 | $18,800 | 0.02% |
| Key Client Fiduciary Advisors, LLC | 13,000 | $24,440 | 0.02% |
| Eudaimonia Partners, LLC | 23,500 | $44,180 | 0.01% |